Comparative study between the use of intermediate acting insulin (NPH) and insulin glargine in children below 8 years with type 1 Diabetes Mellitus
AsaadAboelwafaAbolela;
Abstract
Background: Insulin glargine is a long-acting insulin analogue increasingly used instead of neutral protamine Hagedorn (NPH) insulin in children below 8 years old with type 1 diabetes.
objectives of this study:the aim of the study was to compare the effi
objectives of this study:the aim of the study was to compare the effi
Other data
| Title | Comparative study between the use of intermediate acting insulin (NPH) and insulin glargine in children below 8 years with type 1 Diabetes Mellitus | Authors | AsaadAboelwafaAbolela | Keywords | Comparative study between the use of intermediate acting insulin (NPH) and insulin glargine in children below 8 years with type 1 Diabetes Mellitus | Issue Date | 2013 | Description | Background: Insulin glargine is a long-acting insulin analogue increasingly used instead of neutral protamine Hagedorn (NPH) insulin in children below 8 years old with type 1 diabetes. objectives of this study:the aim of the study was to compare the effi |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 115007G1732.pdf | 154.76 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.